Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
I recently attended a local update for practice nurses who initiate insulin in general practice. One of the many good things about attending this update was that there was group of six or seven of us, so we could all participate. The two diabetes specialist nurses (DSNs) who led the afternoon were great, and allowed time to get answers to questions we had, and deal with difficult patient scenarios we were trying to manage within our own practices.
One very helpful discussion was centred on the use of neutral protamine hagedorn (NPH) insulin versus the newer analogues. Several of us shared how our original training in initiating insulin therapy had been sponsored by one or two drug companies and as a result, we had quickly become familiar with their insulin products. Of course, it was no surprise that they were two of the newer analogues, and we admitted that we had experienced a lack of confidence in using other types of insulin to begin with. With increasing experience, a few of us felt confident now to use human insulin for starting patients on insulin therapy.
http://www.nursinginpractice.com/article/counting-cost-diabetes
One very helpful discussion was centred on the use of neutral protamine hagedorn (NPH) insulin versus the newer analogues. Several of us shared how our original training in initiating insulin therapy had been sponsored by one or two drug companies and as a result, we had quickly become familiar with their insulin products. Of course, it was no surprise that they were two of the newer analogues, and we admitted that we had experienced a lack of confidence in using other types of insulin to begin with. With increasing experience, a few of us felt confident now to use human insulin for starting patients on insulin therapy.
http://www.nursinginpractice.com/article/counting-cost-diabetes